Home  |  Site Map  | Contact
Text size: AA   AA   AA

Investors

Corporate Profile

QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide.

We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases.

QLT's head office is based in Vancouver, Canada and the company is publicly traded on NASDAQ (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT).
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Recent NewsMore >>
DateTitle 
11/07/16QLT Announces Shareholder Approval of Matters Related to Strategic Merger and Record Date for Distribution of WarrantsPrinter Friendly Version
11/01/16QLT Announces Third Quarter 2016 ResultsPrinter Friendly Version
08/09/16QLT Announces Second Quarter 2016 ResultsPrinter Friendly Version

Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts Alerts | IR Contacts IR Contacts | Financial Tear Sheet Tear Sheet
Copyright © 2000-2015 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking